These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 11319503)

  • 1. [Correlations between acne and polycystic ovary. A study of 60 cases].
    Iurassich S; Trotta C; Palagiano A; Pace L
    Minerva Ginecol; 2001 Apr; 53(2):107-11. PubMed ID: 11319503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hormone profile & polycystic ovaries in acne vulgaris.
    Jebraili R; Kaur S; Kanwar AJ; Kataria S; Dash RJ
    Indian J Med Res; 1994 Aug; 100():73-6. PubMed ID: 7927560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ovarian morphology as a predictor of hormonal values in polycystic ovary syndrome.
    van der Westhuizen S; van der Spuy ZM
    Ultrasound Obstet Gynecol; 1996 May; 7(5):335-41. PubMed ID: 8774098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hormonal profiles and prevalence of polycystic ovary syndrome in women with acne.
    Timpatanapong P; Rojanasakul A
    J Dermatol; 1997 Apr; 24(4):223-9. PubMed ID: 9164062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of polycystic ovaries in women with acne.
    Peserico A; Angeloni G; Bertoli P; Marini A; Piva G; Panciera A; Suma V
    Arch Dermatol Res; 1989; 281(7):502-3. PubMed ID: 2532876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polycystic ovaries and associated clinical and biochemical features among women with infertility in a tertiary hospital in Tanzania.
    Pembe AB; Abeid MS
    Tanzan J Health Res; 2009 Oct; 11(4):175-80. PubMed ID: 20734696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of polycystic ovaries in patients with late-onset or persistent acne: hormonal reports.
    Betti R; Bencini PL; Lodi A; Urbani CE; Chiarelli G; Crosti C
    Dermatologica; 1990; 181(2):109-11. PubMed ID: 2147009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ultrasonography of the ovaries and its correlation with clinical and endocrine parameters in infertile women with PCOS.
    Sikka P; Gainder S; Dhaliwal LK; Bagga R; Sialy R; Sahdev S
    Int J Fertil Womens Med; 2007; 52(1):41-7. PubMed ID: 17987887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Marked hyperandrogenemia and acne associated with polycystic ovaries in Greek women with polycystic ovary syndrome.
    Skampardonis N; Kouskoukis A; Karpouzis A; Maroulis G
    Clin Exp Obstet Gynecol; 2011; 38(2):168-71. PubMed ID: 21793282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hormonal and metabolic aspects of acne vulgaris in women with polycystic ovary syndrome.
    Franik G; Bizoń A; Włoch S; Kowalczyk K; Biernacka-Bartnik A; Madej P
    Eur Rev Med Pharmacol Sci; 2018 Jul; 22(14):4411-4418. PubMed ID: 30058676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Free testosterone, luteinizing hormone/follicle stimulating hormone ratio and pelvic sonography in relation to skin manifestations in patients with polycystic ovary syndrome.
    Sharquie KE; Al-Bayatti AA; Al-Ajeel AI; Al-Bahar AJ; Al-Nuaimy AA
    Saudi Med J; 2007 Jul; 28(7):1039-43. PubMed ID: 17603706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endocrinological environment with regard to the number of microcysts in patients with polycystic ovary syndrome.
    Yoshino K; Takahashi K; Eda Y; Okada S; Kitao M
    Hum Reprod; 1992 Oct; 7(9):1201-4. PubMed ID: 1478997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood flow changes in the ovarian and uterine arteries in women with polycystic ovary syndrome who respond to clomiphene citrate: correlation with serum hormone concentrations.
    Zaidi J; Jacobs H; Campbell S; Tan SL
    Ultrasound Obstet Gynecol; 1998 Sep; 12(3):188-96. PubMed ID: 9793191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperandrogenemia association with acne and hirsutism severity in Croatian women with polycystic ovary syndrome.
    Pavičić Baldani D; Škrgatić L; Bukvić Mokos Z; Trgovčić I
    Acta Dermatovenerol Croat; 2013; 21(2):105-12. PubMed ID: 24001418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transvaginal ultrasound imaging, histopathology and endocrinopathy in patients with polycystic ovarian syndrome.
    Takahashi K; Eda Y; Abu-Musa A; Okada S; Yoshino K; Kitao M
    Hum Reprod; 1994 Jul; 9(7):1231-6. PubMed ID: 7962423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of metformin therapy on hyperandrogenism in women with polycystic ovarian syndrome.
    Kazerooni T; Dehghan-Kooshkghazi M
    Gynecol Endocrinol; 2003 Feb; 17(1):51-6. PubMed ID: 12724019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. On the relationship between endocrine and ovulatory abnormalities, and polycystic ovaries as diagnosed by ultrasonography.
    Takahashi K; Yoshino K; Nishigaki A; Eda Y; Kitao M
    Int J Fertil; 1992; 37(4):222-6. PubMed ID: 1354209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polycystic ovary syndrome: a new ultrasonographic and color Doppler pattern.
    Battaglia C; Regnani G; Artini PG; Giulini S; Genazzani AD; Genazzani AR; Volpe A
    Gynecol Endocrinol; 2000 Dec; 14(6):417-24. PubMed ID: 11228062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Serum levels of anti-muller hormone in women with polycystic ovary syndrome and healthy women of reproductive age].
    Parahuleva N; Pehlivanov B; Orbecova M; Deneva T; Uchikova E
    Akush Ginekol (Sofiia); 2013; 52 Suppl 1():16-23. PubMed ID: 24294740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum anti-Müllerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome.
    Piltonen T; Morin-Papunen L; Koivunen R; Perheentupa A; Ruokonen A; Tapanainen JS
    Hum Reprod; 2005 Jul; 20(7):1820-6. PubMed ID: 15802325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.